Preferential expression of c-kit protooncogene transcripts in small cell lung cancer

Related Experiment Videos

Y Sekido1, Y Obata, R Ueda

  • 1First Department of Internal Medicine, Nagoya University School of Medicine, Japan.

Cancer Research
|May 1, 1991
PubMed

Insights

Small cell lung cancer (SCLC) cells express c-kit protooncogenes, unlike other lung cancers. This suggests c-kit may drive SCLC growth through autocrine or paracrine signaling pathways.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Research

Background:

  • Protein-tyrosine kinases are crucial regulators of cell growth.
  • Understanding the molecular basis of small cell lung cancer (SCLC) rapid growth is essential.

Purpose of the Study:

  • To investigate the role of protein-tyrosine kinases in SCLC growth.
  • To identify specific genes involved in SCLC proliferation.

Main Methods:

  • Screening of a complementary DNA library from SCLC cells using viral oncogene probes.
  • Partial sequence analysis to identify isolated clones.
  • Northern blot analysis to assess gene expression in SCLC and non-SCLC tumors and cell lines.
  • Southern blot analysis to detect gene amplification or rearrangement.

Main Results:

  • Four c-kit protooncogenes were identified from fifteen clones hybridized with the v-fms probe.
  • Most SCLC tumors and cell lines expressed c-kit transcripts.
  • Non-SCLC tumors and cell lines did not express c-kit transcripts.
  • No amplification or rearrangement of the c-kit gene was found in SCLC cell lines.

Conclusions:

  • c-kit expression is a distinguishing feature of SCLC, differentiating it from non-SCLC.
  • The c-kit product may be involved in autocrine or paracrine stimulation contributing to SCLC growth.

Related Concept Videos